Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
3.41%
↑ 49% vs avg
Percentile
P64
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
2.29%
Historical baseline
PeriodValue
Q4 20253.41%
Q3 2025-1.15%
Q2 2025-4.82%
Q1 2025-1.22%
Q4 202410.87%
Q3 2024-48.39%
Q2 202421.52%
Q1 2024-46.30%
Q4 2023-145.00%
Q3 2023233.33%
Q2 20235.26%
Q1 20230.00%